早產診斷檢測套組市場規模、佔有率和成長分析（按檢測類型、樣本類型、最終用戶和地區）- 產業預測 2025-2032

2023 年早產診斷檢測套組市場規模為 1.522 億美元，預計將從 2024 年的 1.6377 億美元成長到 2032 年的 2.9426 億美元，預計在預測期內（2025-2032 年）的複合年成長率為 7.6%。

由於早產的盛行率不斷上升以及早期檢測的迫切需求，全球早產診斷檢測檢測套組市場正在經歷顯著成長。這些創新的試劑套件有助於透過分析生物標記和臨床指標及時評估早產的可能性。醫療保健提供者和孕婦意識的提高以及診斷技術的進步正在推動這一市場的擴張。北美和歐洲憑藉其成熟的醫療保健體系佔據了市場佔有率，而亞太地區則在醫療保健投資和認知度不斷提高的推動下，呈現出良好的成長勢頭。向就地檢驗的轉變正在提高風險評估的可及性和速度，特別是在醫療資源有限的地區，擴大了這些診斷工具的覆蓋範圍和影響力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

早產診斷檢測套組市場規模（依檢測類型及複合年成長率） (2025-2032)

• 市場概況
• 胎兒纖連蛋白(fFN)檢測套組
• 胎盤α微球蛋白-1（PAMG-1）檢測套組
• 胰島素樣生長因子結合蛋白質-1（IGFBP-1）檢測套組

早產診斷檢測套組市場規模（依樣本類型及複合年成長率）（2025-2032）

• 市場概況
• 血液樣本
• 尿液樣本
• 陰道分泌物樣本

早產診斷檢測套組市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 診斷實驗室
• 專科門診

早產診斷檢測套組市場規模（依地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Roche Diagnostics（Switzerland）
• Abbott Laboratories（USA）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• BD（Becton, Dickinson and Company）（USA）
• PerkinElmer（USA）
• bioMerieux（France）
• Hologic, Inc.（USA）
• Qiagen（Netherlands）
• Danaher Corporation（USA）
• Cepheid（USA）
• Illumina, Inc.（USA）
• Sysmex Corporation（Japan）
• Agilent Technologies（USA）
• Bio-Rad Laboratories（USA）
• GenMark Diagnostics（USA）
• Luminex Corporation（USA）
• Randox Laboratories（UK）
• NanoString Technologies（USA）
• Myriad Genetics（USA）

結論和建議

Preterm Birth Diagnostic Test Kits Market size was valued at USD 152.2 million in 2023 and is poised to grow from USD 163.77 million in 2024 to USD 294.26 million by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The Global Preterm Birth Diagnostic Test Kits market is experiencing significant growth driven by an increased prevalence of preterm births and the urgent need for early detection. These innovative kits facilitate timely evaluations of potential preterm births through the analysis of biomarkers and clinical indicators. A surge in awareness among healthcare providers and expectant mothers, combined with advancements in diagnostic technology, supports this market expansion. While North America and Europe dominate in market share due to their well-established healthcare systems, the Asia-Pacific region shows promising growth fueled by rising healthcare investments and awareness. The shift towards point-of-care testing enhances the accessibility and speed of risk assessments, particularly in areas with limited healthcare resources, broadening the reach and impact of these diagnostic tools.

Top-down and bottom-up approaches were used to estimate and validate the size of the Preterm Birth Diagnostic Test Kits market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Preterm Birth Diagnostic Test Kits Market Segments Analysis

Global Preterm Birth Diagnostic Test Kits Market is segmented by Test Type, Sample Type, End User and region. Based on Test Type, the market is segmented into Fetal Fibronectin (fFN) Test Kits, Placental Alpha Microglobulin-1 (PAMG-1) Test Kits and Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Test Kits. Based on Sample Type, the market is segmented into Blood Sample, Urine Sample and Vaginal Discharge Sample. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Preterm Birth Diagnostic Test Kits Market

Preterm birth, which occurs when a baby is born before 37 weeks of gestation, poses a substantial global health challenge. The rising prevalence of preterm deliveries is fueling the necessity for precise and dependable diagnostic test kits that can effectively identify and forecast instances of preterm labor. This growing demand is anticipated to continue as healthcare professionals and governmental bodies prioritize strategies aimed at decreasing preterm birth rates while enhancing the health outcomes for both mothers and newborns. As a result, the market for preterm birth diagnostic test kits is expected to expand significantly in response to these needs.

Restraints in the Preterm Birth Diagnostic Test Kits Market

The market for preterm birth diagnostic test kits faces significant constraints due to the stringent regulations imposed on the medical diagnostic industry, aimed at safeguarding patient safety and product effectiveness. The process of developing and launching new diagnostic test kits, particularly those associated with pregnancy and neonatal care, necessitates extensive testing and navigating complex approval pathways. These regulatory challenges can lead to delays in bringing innovative test kits to market, ultimately affecting their accessibility and widespread adoption among healthcare providers. As a result, the long and arduous approval process can hinder advancements and limit the options available to patients and clinicians alike.

Market Trends of the Preterm Birth Diagnostic Test Kits Market

The preterm birth diagnostic test kits market is experiencing a notable trend towards technological advancements, driven by the increasing need for accurate risk assessment of preterm deliveries. Recent innovations have led to the development of highly sensitive and specific tests, utilizing an array of biomarkers, genetic analysis, and proteomics. These enhancements allow healthcare professionals to better predict preterm birth risks, improving patient outcomes through early intervention. As a result, the market is expected to expand significantly, fostering greater adoption of these advanced diagnostic tools in clinical settings. This trend aligns with broader healthcare goals of personalized medicine and improved maternal-fetal health management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Preterm Birth Diagnostic Test Kits Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Fetal Fibronectin (fFN) Test Kits
• Placental Alpha Microglobulin-1 (PAMG-1) Test Kits
• Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Test Kits

Global Preterm Birth Diagnostic Test Kits Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Blood Sample
• Urine Sample
• Vaginal Discharge Sample

Global Preterm Birth Diagnostic Test Kits Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Specialty Clinics

Global Preterm Birth Diagnostic Test Kits Market Size & CAGR (2025-2032)

• North America (Test Type, Sample Type, End User)
  • US
  • Canada
• Europe (Test Type, Sample Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Sample Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Sample Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Sample Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations